Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 82 of 97, showing 5 Applications out of 482 total, starting on record 406, ending on 410

# Protocol No Study Title Investigator(s) & Site(s)

406.

ECCT/14/08/05   Brief Bactericidal Activity of Anti TB drugs
    Brief Bactericidal Activity of Anti-Tuberculosis Drugs   
Principal Investigator(s)
1. Videlis Nzioka Nduba
Site(s) in Kenya
KEMRI-CGHR
 
View

407.

ECCT/14/08/03   STAND Study (Shortening Treatment by Advancing Novel Drugs)
    Long Title:   A Phase 3 Open Label Partially Randomised Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug Sensitive Smear Positive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis       Short Title:   STAND Study (Shortening Treatment by Advancing Novel Drugs)   
Principal Investigator(s)
1. Dr Videlis Nduba
2. Dr Evans Amukoye
Site(s) in Kenya
1. KEMRI-CRDR(East Nairobi) (Nairobi City county)
2. KEMRI-CRDR(West Nairobi) (Nairobi City county)
 
View

408.

ECCT/14/08/02   A5288
    Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)   
Principal Investigator(s)
1. ESTHER MUMBI MAKANGA
Site(s) in Kenya
KEMRI/CDC CLINICAL RESEARCH CENTRE
 
View

409.

ECCT/14/07/01  
    POST STABILIZATION VERSUS URGENT START OF HAART IN HIV-1 INFECTED CHILDREN WITH SEVERE COINFECTION   
Principal Investigator(s)
1. Grace John-Stewart
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisumu East District Hospital (Kisumu county)
 
View

410.

ECCT/14/06/01   ACTG -5279
    Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Dr. Kevin N/A Cain
Site(s) in Kenya
1. KEMRI/WRP CRS (Kericho county)
2. Moi University Clinical Research Center CRS ()12601 (Uasin Gishu county)
 
View